BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
0.326
+0.003 (0.96%)
At close: Jan 31, 2025, 4:00 PM
0.318
-0.008 (-2.45%)
After-hours: Jan 31, 2025, 6:17 PM EST
BioXcel Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -71 | -179.05 | -165.76 | -106.93 | -82.17 | -32.97 | |
| Depreciation & Amortization | 0.31 | 0.32 | 0.33 | 0.3 | 0.19 | 0.16 | |
| Other Amortization | 0.55 | 1.37 | 0.86 | - | - | - | |
| Loss (Gain) From Sale of Assets | - | 0 | 0.02 | 0.05 | - | - | |
| Stock-Based Compensation | 9.95 | 18.61 | 17.34 | 19.46 | 14.61 | 3.14 | |
| Other Operating Activities | -14.39 | -0.44 | 0.39 | - | - | - | |
| Change in Accounts Receivable | 0.73 | 0.18 | -0.25 | - | - | - | |
| Change in Inventory | 0.49 | -0.01 | -1.99 | - | - | - | |
| Change in Accounts Payable | -13.31 | -3.22 | 13.03 | 4.85 | 3.2 | 3.76 | |
| Change in Other Net Operating Assets | 2.58 | 7.23 | 0.68 | 0.13 | -2.18 | -1.19 | |
| Operating Cash Flow | -84.08 | -155.01 | -135.34 | -82.15 | -66.35 | -27.1 | |
| Capital Expenditures | - | -0.02 | -0.14 | -0.45 | -0.32 | -0.87 | |
| Investing Cash Flow | - | -0.02 | -0.14 | -0.45 | -0.32 | -0.87 | |
| Long-Term Debt Issued | - | - | 98.6 | - | - | - | |
| Total Debt Issued | - | - | 98.6 | - | - | - | |
| Net Debt Issued (Repaid) | - | - | 98.6 | - | - | - | |
| Issuance of Common Stock | 35.06 | 27.54 | 0.28 | 102.45 | 274.2 | 17.83 | |
| Repurchase of Common Stock | -0.01 | -0.03 | - | - | -9.02 | - | |
| Other Financing Activities | -0.55 | -0.99 | -2.65 | - | -17.82 | - | |
| Financing Cash Flow | 34.51 | 26.52 | 96.24 | 102.45 | 247.36 | 17.83 | |
| Net Cash Flow | -49.57 | -128.5 | -39.24 | 19.85 | 180.69 | -10.14 | |
| Free Cash Flow | -84.08 | -155.03 | -135.48 | -82.6 | -66.67 | -27.97 | |
| Free Cash Flow Margin | -3694.24% | -11233.77% | -36128.00% | - | - | - | |
| Free Cash Flow Per Share | -2.35 | -5.32 | -4.84 | -3.13 | -3.07 | -1.72 | |
| Cash Interest Paid | 7.55 | 7.55 | 2.7 | 0.04 | 0.03 | 0.06 | |
| Levered Free Cash Flow | -57.16 | -96.55 | -75.59 | -42.62 | -35.86 | -15.85 | |
| Unlevered Free Cash Flow | -48.63 | -89.61 | -71.32 | -42.6 | -35.84 | -15.84 | |
| Change in Net Working Capital | 12.51 | 3.76 | -10.93 | -4.93 | -1.11 | -2.73 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.